OTCMKTS:FSNUY Fresenius SE & Co. (FSNUY) Stock Price, News & Analysis $12.50 +0.40 (+3.31%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About Fresenius SE & Co. Stock (OTCMKTS:FSNUY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Fresenius SE & Co. alerts:Sign Up Key Stats Today's Range$12.22▼$12.5150-Day Range$10.40▼$12.2452-Week Range$10.33▼$33.93Volume353,414 shsAverage Volume132,779 shsMarket Capitalization$28.16 billionP/E Ratio16.67Dividend Yield1.60%Price TargetN/AConsensus RatingBuy Company Overview Fresenius SE & Co. KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co. brings together a portfolio of specialized healthcare businesses under one corporate umbrella. The company operates through four main business segments. Fresenius Medical Care is the largest provider of renal care products and services, including dialysis machines, disposables and clinic operations. Fresenius Kabi offers a broad range of lifesaving medicines, infusion therapies, clinical nutrition and medical devices for intravenous drug delivery. Fresenius Helios manages a network of acute care hospitals and outpatient facilities across Europe, while Fresenius Vamed specializes in planning, construction and management of healthcare projects and facilities, supporting clients from conception through operation. Fresenius serves patients and healthcare providers in more than 100 countries, with production sites, research centers and clinical operations spanning Europe, North America, Asia-Pacific and Latin America. The company emphasizes continuous innovation, investing in research and development to enhance patient outcomes and streamline care delivery. Under the leadership of Chief Executive Officer Dr. Stephan Sturm, Fresenius pursues a strategy of geographic expansion and portfolio optimization to address evolving global healthcare needs.AI Generated. May Contain Errors. Read More Receive FSNUY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius SE & Co. and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FSNUY Stock News HeadlinesFresenius SE & Co KGaA ADR FSNUYJune 24, 2026 | morningstar.comMFresenius SE & Co. KGaA (0OO9) Receives a Buy from BarclaysJune 17, 2026 | theglobeandmail.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.July 6 at 1:00 AM | Porter & Company (Ad)Assessing Fresenius SE KGaA (XTRA:FRE) Valuation After Recent Earnings And Shareholder ReturnsMarch 1, 2026 | finance.yahoo.comFresenius SE Earnings Call Highlights Growth MomentumFebruary 28, 2026 | tipranks.comFresenius SE & Co. KGaA (FSNUY) Q4 2025 Earnings Call TranscriptFebruary 25, 2026 | seekingalpha.comGermany's Fresenius beats revenue expectations in fourth quarterFebruary 25, 2026 | msn.comFresenius SE & Co. KGaA (FSNUY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 14, 2026 | seekingalpha.comSee More Headlines FSNUY Stock Analysis - Frequently Asked Questions How have FSNUY shares performed this year? Fresenius SE & Co.'s stock was trading at $14.33 at the beginning of the year. Since then, FSNUY shares have decreased by 12.9% and is now trading at $12.48. How were Fresenius SE & Co.'s earnings last quarter? Fresenius SE & Co. (OTCMKTS:FSNUY) released its quarterly earnings data on Wednesday, May, 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by $0.01. The firm had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. Fresenius SE & Co. had a trailing twelve-month return on equity of 10.09% and a net margin of 6.55%. How do I buy shares of Fresenius SE & Co.? Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/06/2026Today7/06/2026Next Earnings (Estimated)8/05/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryMedical Equipment Current SymbolOTCMKTS:FSNUY CIK904868 Webwww.fresenius.com Phone(496) 172-6080FaxN/AEmployees178,394Year Founded1912Profitability EPS (Trailing Twelve Months)$0.75 Trailing P/E Ratio16.67 Forward P/E Ratio12.14 P/E GrowthN/ANet Income$1.43 billion Net Margins6.55% Pretax Margin9.49% Return on Equity10.09% Return on Assets4.72% Debt Debt-to-Equity Ratio0.41 Current Ratio1.27 Quick Ratio0.98 Sales & Book Value Annual Sales$25.87 billion Price / Sales1.09 Cash Flow$1.61 per share Price / Cash Flow7.74 Book Value$9.93 per share Price / Book1.26Miscellaneous Outstanding Shares2,252,950,000Free FloatN/AMarket Cap$28.16 billion OptionableNot Optionable Beta0.63 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:FSNUY) was last updated on 7/6/2026 by MarketBeat.com Staff. From Our PartnersThree companies about to leapfrog Nvidia [And transform the entire industry]The government just committed $200 billion to building computer chips on American soil - one of the largest te...Eagle Publishing | SponsoredAre you leaving Social Security money on the table?Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....Money Pickle | SponsoredAmazon, Google, Meta, and Microsoft just committed $700 billionAmazon, Google, Meta, and Microsoft have committed $700 billion to AI infrastructure in 2026 alone - more than...True Market Insiders | SponsoredIf You Have $50k+ on Coinbase, This Will Ruin Your DayI spent two years reverse-engineering BlackRock's exact playbook. The same framework that generates them $16.1...Decentralized Masters | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredThe Warsh Fed and what it could mean for your savingsThe Fed just changed hands, and Reagan Gold Group says there may be a short window before the impact shows up ...Reagan Gold Group | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius SE & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius SE & Co. With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
